无已知基因突变家族性乳腺癌风险女性的筛查准确性:个体患者数据荟萃分析
该个体患者数据荟萃分析纳入6项前瞻性筛查试验中无已知基因突变但乳腺癌家族史强烈的女性,评估年度钼靶联合或不联合MRI的筛查准确性。结果显示,钼靶单独敏感性55%、特异性94%;MRI单独敏感性89%、特异性83%;钼靶联合MRI敏感性增至98%但特异性降至79%。结论:在该人群中,钼靶联合MRI大幅提高筛查敏感性,但也降低特异性。
要点
- 无已知基因突变但家族史强烈的女性,乳腺癌发生率为每1000人年12例(95%CI 9.3-14)。
- 钼靶联合MRI较钼靶单独敏感性从55%升至98%(P<0.01),特异性从94%降至79%(P<0.01)。
- MRI单独敏感性89%、特异性83%;钼靶单独敏感性55%、特异性94%。
核心结论
- 在无已知基因突变但乳腺癌家族史强烈的女性中,钼靶联合MRI较钼靶单独大幅提高筛查敏感性,但也降低特异性。
研究设计与样本
- 个体患者数据荟萃分析,纳入6项前瞻性筛查试验,仅分析无已知基因突变且乳腺癌家族史强烈的女性,共2226例(中位年龄41岁,IQR 35-47),随访7478人年,采用广义线性混合模型估计并比较筛查准确性。
主要发现
- 乳腺癌发生率为每1000人年12例(95%CI 9.3-14)。
- 钼靶筛查敏感性55%(SE 7.0),特异性94%(SE 1.3)。
- MRI单独筛查敏感性89%(SE 4.6),特异性83%(SE 2.8)。
- 钼靶联合MRI较钼靶单独敏感性升至98%(SE 1.8,P<0.01),特异性降至79%(SE 2.7,P<0.01)。
临床怎么用
- 对于无已知基因突变但乳腺癌家族史强烈的女性,在一般人群筛查项目之外,年度钼靶联合或不联合MRI的筛查准确性数据可供临床参考。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Women with a strong family history of breast cancer (BC) and without a known gene mutation have an increased risk of developing BC. We aimed to investigate the accuracy of screening using annual mammography with or without magnetic resonance imaging (MRI) for these women outside the general population screening program. METHODS: An individual patient data (IPD) meta-analysis was conducted using IPD from six prospective screening trials that had included women at increased risk for BC: only women with a strong familial risk for BC and without a known gene mutation were included in this analysis. A generalised linear mixed model was applied to estimate and compare screening accuracy (sensitivity, specificity and predictive values) for annual mammography with or without MRI. RESULTS: There were 2226 women (median age: 41 years, interquartile range 35-47) with 7478 woman-years of follow-up, with a BC rate of 12 (95% confidence interval 9.3-14) in 1000 woman-years. Mammography screening had a sensitivity of 55% (standard error of mean [SE] 7.0) and a specificity of 94% (SE 1.3). Screening with MRI alone had a sensitivity of 89% (SE 4.6) and a specificity of 83% (SE 2.8). Adding MRI to mammography increased sensitivity to 98% (SE 1.8, P < 0.01 compared to mammography alone) but lowered specificity to 79% (SE 2.7, P < 0.01 compared with mammography alone). CONCLUSION: In this population of women with strong familial BC risk but without a known gene mutation, in whom BC incidence was high both before and after age 50, adding MRI to mammography substantially increased screening sensitivity but also decreased its specificity.
引用
- Phi XA, Houssami N, Hooning MJ, et al. Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis. Eur J Cancer. 2017. PMID: 28886475. doi:10.1016/j.ejca.2017.07.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。